Company news
Zhejiang Jianfeng Group Co. Ltd. news in 2025
Zhejiang Jianfeng Group Co. Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Subsidiary's Passing GMP Compliance Inspection for Drugs
December 23, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
November 21, 2025
Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary
November 14, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 3, 2025
Announcement on Canceling the Board of Supervisors and Amending the "Articles of Association" and Some Internal Control Systems
October 29, 2025
Announcement on Progress in Changes in Equity Structure of Indirect Controlling Shareholder
September 29, 2025
Announcement on Initially Repurchasing the Company's Shares through Call Auction
September 26, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 19, 2025
Announcement on Obtaining Letter of Commitment for Special Loans for Stock Repurchase from Financial Institution
September 16, 2025
2025 Semi-annual Report
August 29, 2025
Indicative Announcement on Changes in Equity Structure of Indirect Controlling Shareholder
August 25, 2025
Announcement on Resolutions of the 11th Meeting of the 12th Board of Directors
August 15, 2025
Announcement on Adjusting Upper Limit of Shares Repurchase Price after Implementation Dividend Distribution for 2024
July 15, 2025
Announcement on Expected Increase in Semi-annual Performance for 2025
July 14, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 8, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
June 27, 2025
Announcement on By-election of Director
June 11, 2025
Announcement on Progress in Providing Guarantees for Wholly-owned Subsidiaries
June 9, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 22, 2025
Announcement on the Retirement and Resignation of Deputy General Manager
May 16, 2025
Report for Q1 2025
April 29, 2025
Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders without Sales Limits Concerning Shares Repurchase
April 25, 2025
Announcement on Renewing Engagement of Accounting Firm
April 21, 2025
Announcement on Progress of Joint-stock subsidiary Tasly Pharmaceutical Group Co., Ltd. Selling Partial Equity
March 31, 2025
Announcement on Progress in Changing Equity Structure of Controlling Shareholder
January 24, 2025
Indicative Announcement on Changes in Equity Structure of Controlling Shareholder
January 21, 2025
Announcement on the Resolutions of the 6th Meeting of the 12th Board of Directors
January 3, 2025